KALA BIO, Inc.
KALA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479419
No open-market purchases or sales by KALA BIO, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.21M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding KALA BIO, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 24 | 32 | +8 |
| Shares | 1.75M | 2.84M | +1.09M (+62.4%) |
| Value | $2.69M | $1.58M | −$1.11M (−41.2%) |
New holders (12)
Institutions that held KALA BIO, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 144,347 | $80.2K | 0.00% |
| Virtu Financial LLC | 85,505 | $48.0K | 0.00% |
| Citadel Advisors LLC | 56,381 | $31.3K | 0.00% |
| Renaissance Technologies LLC | 40,905 | $22.7K | 0.00% |
| XTX Topco Ltd | 28,278 | $15.7K | 0.00% |
| Two Sigma Investments, LP | 26,900 | $15.0K | 0.00% |
| Two Sigma Securities, LLC | 13,105 | $7.29K | 0.00% |
| StoneX Group Inc. | 12,255 | $6.81K | 0.00% |
| SG Americas Securities, LLC | 10,359 | $6.00K | 0.00% |
| Fortitude Family Office, LLC | 709 | $394 | 0.00% |
| International Assets Investment Management, LLC | 110 | $61 | 0.00% |
| Motiv8 Investments LLC | 2 | $0 | 0.00% |
Sold out (4)
Institutions that held KALA BIO, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Marex Group plc | 14,500 | $35.0K |
| Tower Research Capital LLC (TRC) | 5,076 | $7.77K |
| Caitong International Asset Management Co., Ltd | 736 | $1.13K |
| The PNC Financial Services Group, Inc. | 46 | $70 |